Stockscreener 앱 받기
1.175
2.08%
-0.025
전일 마감가:
$1.20
열려 있는:
$1.2
하루 거래량:
341.39K
Relative Volume:
0.21
시가총액:
$447.20M
수익:
$106.34M
순이익/손실:
$-74.66M
주가수익비율:
-1.2368
EPS:
-0.95
순현금흐름:
$-46.12M
1주 성능:
-0.42%
1개월 성능:
+9.81%
6개월 성능:
-44.31%
1년 성능:
-53.19%
1일 변동 폭
$1.17
$1.22
1주일 범위
$1.05
$1.22
52주 변동 폭
$0.9712
$2.74
Standard Biotools Inc Stock (LAB) Company Profile
명칭
Standard Biotools Inc
전화
(650) 266-6000
주소
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.18 | 447.20M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
132.40 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.40 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.09 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.59 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.42 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-27 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | 개시 | TD Cowen | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-12 | 개시 | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Standard BioTools Inc (LAB) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
Invesco Ltd. Acquires 12,194 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Standard BioTools Inc (LAB) requires closer examination - uspostnews.com
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Standard BioTools Inc [LAB] Stock bought by Insider Casdin Partners Master Fund, L for $5.13 million - knoxdaily.com
Legal & General Group Plc Cuts Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Stock Performance Spotlight: Standard BioTools Inc (LAB) Ends the Day at 1.16, Down by -5.69 - DWinneX
Standard BioTools Inc [LAB] Records 50-Day SMA of $1.1772 - knoxdaily.com
Standard BioTools (LAB) Introduces Advanced Proteomic Products a - GuruFocus
Standard BioTools Inc (LAB)’s stock price in review: A technical analysis - uspostnews.com
Standard BioTools Inc (LAB) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 - The Manila Times
Standard BioTools Inc. Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 - marketscreener.com
Analysts Advise You To Maintain Your Position In Standard BioTools Inc (NASDAQ: LAB) - Stocksregister
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025 - The Manila Times
Standard BioTools Inc. to Announce First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq
Standard BioTools Earnings Preview: Key Q1 2025 Updates Coming May 6What to Watch - Stock Titan
Standard BioTools Inc. (NASDAQ:LAB) Shares Acquired by Geode Capital Management LLC - Defense World
Positive week for Standard BioTools Inc. (NASDAQ:LAB) institutional investors who lost 58% over the past year - simplywall.st
Vanguard Group Inc. Decreases Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Bought by American Century Companies Inc. - Defense World
Corebridge Financial Inc. Sells 11,070 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
40,166 Shares in Standard BioTools Inc. (NASDAQ:LAB) Acquired by KLP Kapitalforvaltning AS - Defense World
Major Improvements In Standard BioTools Inc (LAB) Stock Need To Be Considered - stocksregister.com
Commonwealth Equity Services LLC Sells 51,993 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies - marketscreener.com
Fluidigm stock plunges to 52-week low of $0.98 amid sharp decline - Investing.com UK
Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN
HighTower Advisors LLC Has $162,000 Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Swiss National Bank - Defense World
What Will Standard BioTools Inc (NASDAQ: LAB) Be Like In 2025 - Stocks Register
Charles Schwab Investment Management Inc. Sells 112,434 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Bank of New York Mellon Corp Reduces Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools at KeyBanc Forum: Strategic Moves in Plasma Proteomics By Investing.com - Investing.com Canada
STANDARD BIOTOOLS INC. SEC 10-K Report - TradingView
Standard BioTools Inc. (LAB) reports earnings - qz.com
Rhumbline Advisers Sells 10,975 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock - Investing.com India
Casdin Partners master fund buys $5.13 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Casdin Partners master fund buys $5.13 million in Standard BioTools stock - Investing.com
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Biochips Market Generated Opportunities, Future Scope 2025-2032 | PerkinElmer, Inc., Fluidigm Corporation, Illumina - openPR
Q1 Earnings Forecast for Standard BioTools Issued By KeyCorp - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Simply Wall St
ARK Investment Management LLC Lowers Stake in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools to Participate in Upcoming Investor Conferences -February 27, 2025 at 04:02 pm EST - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Quarterly Earnings Results, Hits Estimates - MarketBeat
Standard BioTools Inc. Faces Revenue Decline Amid Market Challenges - TipRanks
Standard BioTools to Participate in Upcoming Investor Conferences - The Manila Times
Standard BioTools downgraded to Sector Weight from Overweight at KeyBanc - TipRanks
Standard Biotools Inc (LAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.57%
0.08%
자본화:
|
볼륨(24시간):